Chengdu Bojia Pharmaceutical Co., Ltd.
Company Details
Company Introduction
Chengdu Bojia Pharmaceutical Co., Ltd. was established in 2009. Located in Chongzhou Industrial Concentration Area in Chengdu, our company has transportation advantage. Our company was renamed from Chongzhou Subsidiary which is called Sichuan Keruide Kaihua Pharmaceutical Co. Ltd. Our company focuses on the R&D and manufacture of high-tech bulk pharmaceutical, especially hydroxyethyl starch. Chengdu Bojia Pharmaceutical Co., Ltd. successfully passed SFDA Inspection for GMP compliance in 2009. Hydroxyethyl Starch 130/0.4 was authorized the certification of production by SFDA in 2006 and Hydroxyethyl Starch 200/0.5 was submitted to the application of certification in 2008. Meanwhile, Hydroxyethyl Starch 480/0.7 is under study.Since we entered into the production of Hydroxyethyl Starch series in 2006, our company has accumulated rich experience in production.1. Advanced production technology, stable quality2. High efficiency liquid chromatography for the detection of molecular weight and distribution; simple and accurate for quality control3. To ensure the quality and safety, we adopt bacterial endotoxin inspection method to substitute domestic rabbit method. At present, we can reach 5EU/g Level.4. Large batch of finished goods, 800kg/batch If you are interested in any of our products or would like to discuss a custom order, please feel free to contact us. We are looking forward to forming successful business relationships with new clients around the world in the near future.
Company Information
Company Product
- Hydroxyethyl Starch 200/0.5 APIhydroxyethyl starch130/0.4 pharmaceutical grade fluid therapyHES 200/0.5 pharmaceutical grade starch powderhydroxyethyl starch 130/0.4 Active pharmaceutical ingredientHydroxyethyl Starch 130/0.4 from waxy corn intravenous injectionmedicine grade starch HES 130/0.4 best plasma substitute starchwaxy corn starchnew generation Hydroxyethyl Starch 130/0.4 surgicalpharmaceutical grade hydroxyethyl starchHydroxyethyl Starch 130/0.4 pharmaceutical raw materialwaxy corn Hydroxyethyl Starch 130/0.4 APIhydroxyethyl starch130/0.4 for large volume parenteral formulation used for surgery blood loss plasma substitutePharmaceutical raw material drug hydroxyethyl starch 130/0.4 the best plasma substitute producthydroxyethyl starch 130/0.4 API the best plasma substitute product medicinenew generation hydroxyethyl starch130/0.4 pharmaceutical raw materialplasma substitute HES 200/0.5MF (C6H10O5)m(C2H5O)n Hydroxyethyl starch 130/0.4New generation Hydroxyethyl Starch 130/0.4 pharmaceutical grade best plasma substituteHydroxyethyl Starch130/0.4 Pharmaceutical grade starchPharmaceutical raw material Hydroxyethyl Starch 130/0.4 CAS no.: 9005-27-0new generation Hydroxyethyl Starch 130/0.4 pharmaceutical gradeplasma substitute products Hydroxyethyl starch medicinehes waxy maize starch pharmaceutical gradeCAS no. 9005-27-0 Hydroxyethyl Starch pharmaceuticalPharmaceutical raw material Hydroxyethyl starch 130/0.4 medicineHydroxyethyl Starch 130/0.4 grade Pharmaceuticalstarch ether Hydroxyethyl starch 130/0.4colloid volume treatment HESGMP certificated Hydroxyethyl Starch 130/0.4 best plasma substitutestarch derivative Hydroxyethyl Starch 130/0.4raw material drug Hydroxyethyl Starch 130/0.4starch powder Hydroxyethyl Starch 130/0.4Hydroxyethyl Starch 130/0.4 fluid therapy new health supplementsHydroxyethyl Starch 130/0.4 medicine materialHydroxyethyl Starch 130/0.4 pure health supplementsbest plasma substitute API